In addition, important cellular modulators, such as non-coding RNAs, Ets-1, CEBPG, ARID1A, SNAI2 and HRD1 (see Table 2), could significantly regulate SLC7A11 expression in ovarian cancer cells, suggesting that these modulators could be potential therapeutic targets in ovarian cancer patients. This evidence concerns the gene SLC7A11 and ovarian cancer.